Spain · Delayed Price · Currency is EUR NBI Bearings Europe Statistics
Total Valuation
BME:NBI has a market cap or net worth of EUR 36.22 million. The enterprise value is 69.12 million.
| Market Cap | 36.22M |
| Enterprise Value | 69.12M |
Important Dates
The next estimated earnings date is Monday, May 4, 2026.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:NBI has 12.15 million shares outstanding. The number of shares has increased by 1.24% in one year.
| Current Share Class | 12.15M |
| Shares Outstanding | 12.15M |
| Shares Change (YoY) | +1.24% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 53.77% |
| Owned by Institutions (%) | 16.47% |
| Float | 4.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 60.04 |
| PS Ratio | 0.74 |
| PB Ratio | 2.07 |
| P/TBV Ratio | 3.12 |
| P/FCF Ratio | 9.22 |
| P/OCF Ratio | 4.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.62, with an EV/FCF ratio of 17.59.
| EV / Earnings | -70.40 |
| EV / Sales | 1.42 |
| EV / EBITDA | 9.62 |
| EV / EBIT | 20.55 |
| EV / FCF | 17.59 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 3.28.
| Current Ratio | 2.12 |
| Quick Ratio | 1.18 |
| Debt / Equity | 3.28 |
| Debt / EBITDA | 7.99 |
| Debt / FCF | 14.61 |
| Interest Coverage | 1.44 |
Financial Efficiency
Return on equity (ROE) is -5.19% and return on invested capital (ROIC) is 6.62%.
| Return on Equity (ROE) | -5.19% |
| Return on Assets (ROA) | 2.23% |
| Return on Invested Capital (ROIC) | 6.62% |
| Return on Capital Employed (ROCE) | 5.31% |
| Weighted Average Cost of Capital (WACC) | 4.34% |
| Revenue Per Employee | 140,521 |
| Profits Per Employee | -2,830 |
| Employee Count | 347 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 0.88 |
Taxes
In the past 12 months, BME:NBI has paid 213,320 in taxes.
| Income Tax | 213,320 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.31% in the last 52 weeks. The beta is 0.34, so BME:NBI's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -11.31% |
| 50-Day Moving Average | 3.10 |
| 200-Day Moving Average | 3.07 |
| Relative Strength Index (RSI) | 24.54 |
| Average Volume (20 Days) | 317 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:NBI had revenue of EUR 48.76 million and -981,884 in losses. Loss per share was -0.08.
| Revenue | 48.76M |
| Gross Profit | 25.46M |
| Operating Income | 3.36M |
| Pretax Income | -744,117 |
| Net Income | -981,884 |
| EBITDA | 7.19M |
| EBIT | 3.36M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 24.80 million in cash and 57.40 million in debt, with a net cash position of -32.60 million or -2.68 per share.
| Cash & Cash Equivalents | 24.80M |
| Total Debt | 57.40M |
| Net Cash | -32.60M |
| Net Cash Per Share | -2.68 |
| Equity (Book Value) | 17.49M |
| Book Value Per Share | 1.41 |
| Working Capital | 31.89M |
Cash Flow
In the last 12 months, operating cash flow was 7.97 million and capital expenditures -4.04 million, giving a free cash flow of 3.93 million.
| Operating Cash Flow | 7.97M |
| Capital Expenditures | -4.04M |
| Depreciation & Amortization | 3.82M |
| Net Borrowing | -8.53M |
| Free Cash Flow | 3.93M |
| FCF Per Share | 0.32 |
Margins
Gross margin is 52.22%, with operating and profit margins of 6.90% and -2.01%.
| Gross Margin | 52.22% |
| Operating Margin | 6.90% |
| Pretax Margin | -1.53% |
| Profit Margin | -2.01% |
| EBITDA Margin | 14.74% |
| EBIT Margin | 6.90% |
| FCF Margin | 8.06% |
Dividends & Yields
BME:NBI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.24% |
| Shareholder Yield | -1.24% |
| Earnings Yield | -2.71% |
| FCF Yield | 10.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:NBI has an Altman Z-Score of 1.62 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.62 |
| Piotroski F-Score | 5 |